• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺良性转移性平滑肌瘤和静脉内平滑肌瘤病的分子遗传学分析:一项使用全外显子组测序的比较研究

Molecular genetic analysis of pulmonary benign metastasizing leiomyoma and intravenous leiomyomatosis: a comparative study using whole exome sequencing.

作者信息

Li Jin, Zeng Jiafei, Luo Shuai, Wang Jinjing

机构信息

Department of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, People's Republic of China.

Department of Pathology, Tongren People's Hospital, Tongren, Guizhou, People's Republic of China.

出版信息

Discov Oncol. 2025 May 28;16(1):939. doi: 10.1007/s12672-025-02551-x.

DOI:10.1007/s12672-025-02551-x
PMID:40434516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12119447/
Abstract

OBJECTIVE

Benign Metastasizing Leiomyoma (BML) and Intravenous Leiomyomatosis (IVL) are rare uterine-derived smooth muscle tumors. Although both exhibit histologically benign and similar features, they demonstrate aggressive biological behaviors. Currently, molecular genetic studies on BML and IVL are limited, and no comparative research on their genetic variations has been reported. To investigate the genetic basis underlying their shared aggressive phenotypes, this study employs whole-exome sequencing (WES) to conduct a molecular genetic comparison between the two entities. The aim is to explore potential genetic variations that may reveal common pathological pathways shared by these diseases, thereby enhancing our understanding of the molecular mechanisms driving their invasiveness.

METHODS

A pulmonary BML case and an IVL case underwent analysis, with paraffin-embedded tumor tissues subjected to WES. Mutant genes were screened and comparatively analyzed between the two cases.

RESULTS

WES revealed 15 single nucleotide polymorphism (SNP) genetic mutations in the BML case: HFM1, SCN10A, HEXA, SLC7A14, TEP1, KCNJ12, KCNJ18, DNAJB12, ACOX3, ABCC2, RASA1, ALOX15B, TCIRG1, COL5A3, and MCCC2. In the IVL case, 18 mutant genes were observed: CADPS2, GPSM2, REEP4, KCNJ12, KCNJ18, DUSP15, PDE11A, TCIRG1, KLHL33, PAH, MYO18A, FBLN7, ATP7B, MYO7A, MLKL, LRP10, KRT15, and HEPH. The mutations were consistent across both samples in this case. Shared mutations in BML and IVL cases included TCIRG1, KCNJ12, and KCNJ18.

CONCLUSION

BML and IVL exhibit distinct gene mutations in tumor development, with certain shared mutations.

摘要

目的

良性转移性平滑肌瘤(BML)和静脉内平滑肌瘤病(IVL)是罕见的源自子宫的平滑肌肿瘤。尽管两者在组织学上均表现为良性且具有相似特征,但它们表现出侵袭性生物学行为。目前,关于BML和IVL的分子遗传学研究有限,且尚未有关于它们基因变异的比较研究报道。为了探究其共同侵袭性表型背后的遗传基础,本研究采用全外显子组测序(WES)对这两种实体进行分子遗传学比较。目的是探索可能揭示这些疾病共同病理途径的潜在基因变异,从而加深我们对驱动其侵袭性的分子机制的理解。

方法

对1例肺部BML病例和1例IVL病例进行分析,对石蜡包埋的肿瘤组织进行WES。筛选并比较分析两例病例中的突变基因。

结果

WES在BML病例中揭示了15个单核苷酸多态性(SNP)基因突变:HFM1、SCN10A、HEXA、SLC7A14、TEP1、KCNJ12、KCNJ18、DNAJB12、ACOX3、ABCC2、RASA1、ALOX15B、TCIRG1、COL5A3和MCCC2。在IVL病例中,观察到18个突变基因:CADPS2、GPSM2、REEP4、KCNJ12、KCNJ18、DUSP15、PDE11A、TCIRG1、KLHL33、PAH、MYO18A、FBLN7、ATP7B、MYO7A、MLKL、LRP10、KRT15和HEPH。在该病例的两个样本中,突变情况一致。BML和IVL病例中的共同突变包括TCIRG1、KCNJ12和KCNJ18。

结论

BML和IVL在肿瘤发生发展中表现出不同的基因突变,但存在某些共同突变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/90bbe24dda78/12672_2025_2551_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/1bc72a146c06/12672_2025_2551_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/5b4b3d8bee2c/12672_2025_2551_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/80c79bf1d13e/12672_2025_2551_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/af168bf0aadc/12672_2025_2551_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/6e56423d1799/12672_2025_2551_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/bc925837ef44/12672_2025_2551_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/a4db26e70ea7/12672_2025_2551_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/90bbe24dda78/12672_2025_2551_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/1bc72a146c06/12672_2025_2551_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/5b4b3d8bee2c/12672_2025_2551_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/80c79bf1d13e/12672_2025_2551_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/af168bf0aadc/12672_2025_2551_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/6e56423d1799/12672_2025_2551_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/bc925837ef44/12672_2025_2551_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/a4db26e70ea7/12672_2025_2551_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0136/12119447/90bbe24dda78/12672_2025_2551_Fig8_HTML.jpg

相似文献

1
Molecular genetic analysis of pulmonary benign metastasizing leiomyoma and intravenous leiomyomatosis: a comparative study using whole exome sequencing.肺良性转移性平滑肌瘤和静脉内平滑肌瘤病的分子遗传学分析:一项使用全外显子组测序的比较研究
Discov Oncol. 2025 May 28;16(1):939. doi: 10.1007/s12672-025-02551-x.
2
Leiomyomatosis with vascular invasion. A unified pathogenesis regarding leiomyoma with vascular microinvasion, benign metastasizing leiomyoma and intravenous leiomyomatosis.伴有血管侵犯的平滑肌瘤病。关于伴有血管微侵犯的平滑肌瘤、良性转移性平滑肌瘤和静脉内平滑肌瘤病的统一发病机制。
Virchows Arch. 1994;425(5):541-5. doi: 10.1007/BF00197559.
3
Whole exome sequencing of benign pulmonary metastasizing leiomyoma reveals mutation in the BMP8B gene.良性转移性肺平滑肌瘤的全外显子组测序揭示了BMP8B基因的突变。
BMC Med Genet. 2018 Jan 31;19(1):20. doi: 10.1186/s12881-018-0537-5.
4
Benign Metastasizing Leiomyomatosis to the Skin and Lungs, Intravenous Leiomyomatosis, and Leiomyomatosis Peritonealis Disseminata: A Series of Five Cases.良性转移性平滑肌瘤病至皮肤和肺部、静脉内平滑肌瘤病和播散性腹膜平滑肌瘤病:五例系列病例。
Oncologist. 2022 Feb 3;27(1):e89-e98. doi: 10.1093/oncolo/oyab019.
5
Intravenous leiomyomatosis in the inferior vena cava and right atrium with pulmonary benign metastasizing leiomyoma secondary to a pelvic arteriovenous fistula: A case report and literature review.下腔静脉和右心房静脉内平滑肌瘤病伴良性转移平滑肌瘤至肺:病例报告及文献复习。
Cardiovasc Pathol. 2024 Nov-Dec;73:107685. doi: 10.1016/j.carpath.2024.107685. Epub 2024 Aug 12.
6
Molecular Profiling of Benign Metastasizing Leiomyoma of the Uterus Revealing Unique Novel Therapeutic Targets.子宫良性转移性平滑肌瘤的分子剖析揭示独特的新型治疗靶点。
Cureus. 2020 Apr 16;12(4):e7701. doi: 10.7759/cureus.7701.
7
MED12 exon 2 mutation is uncommon in intravenous leiomyomatosis: clinicopathologic features and molecular study.MED12 外显子 2 突变在静脉内平滑肌瘤病中不常见:临床病理特征和分子研究。
Hum Pathol. 2020 May;99:36-42. doi: 10.1016/j.humpath.2020.03.011. Epub 2020 Mar 30.
8
Leiomyomas beyond the uterus; benign metastasizing leiomyomatosis with paraaortic metastasizing endometriosis and intravenous leiomyomatosis: a case series and review of the literature.子宫外平滑肌瘤;伴主动脉旁转移性子宫内膜异位症及静脉内平滑肌瘤病的良性转移性平滑肌瘤病:病例系列及文献复习
Arch Gynecol Obstet. 2015 Jan;291(1):223-30. doi: 10.1007/s00404-014-3356-8. Epub 2014 Jul 22.
9
Intravenous leiomyomatosis of the uterus with pulmonary metastases or a case with benign metastasizing leiomyoma?子宫静脉内平滑肌瘤病伴肺转移还是良性转移性平滑肌瘤病例?
Anticancer Res. 2009 Feb;29(2):495-6.
10
Intravenous leiomyomatosis is inclined to a solid entity different from uterine leiomyoma based on RNA-seq analysis with RT-qPCR validation.静脉内平滑肌瘤病倾向于一种基于 RNA 测序分析并经 RT-qPCR 验证的与子宫平滑肌瘤不同的实体。
Cancer Med. 2020 Jul;9(13):4581-4592. doi: 10.1002/cam4.3098. Epub 2020 May 5.

本文引用的文献

1
Uterine Smooth Muscle Tumors: An Overview.子宫平滑肌肿瘤:概述。
Adv Anat Pathol. 2024 Nov 1;31(6):397-410. doi: 10.1097/PAP.0000000000000446. Epub 2024 Apr 19.
2
Glycolysis-related biomarker TCIRG1 participates in regulation of renal cell carcinoma progression and tumor immune microenvironment by affecting aerobic glycolysis and AKT/mTOR signaling pathway.糖酵解相关生物标志物TCIRG1通过影响有氧糖酵解和AKT/mTOR信号通路参与肾细胞癌进展和肿瘤免疫微环境的调控。
Cancer Cell Int. 2023 Aug 30;23(1):186. doi: 10.1186/s12935-023-03019-0.
3
[Chinese expert consensus on clinical diagnosis and treatment of pelvic venous leiomyomatosis].
《盆腔静脉平滑肌瘤病临床诊疗中国专家共识》
Zhonghua Fu Chan Ke Za Zhi. 2023 Apr 25;58(4):252-258. doi: 10.3760/cma.j.cn112141-20230104-00005.
4
Benign metastasizing uterine leiomyoma with lymphatic and pulmonary metastases: a case report and literature review.良性转移性子宫平滑肌瘤伴淋巴和肺转移:病例报告及文献复习。
BMC Womens Health. 2023 Apr 1;23(1):154. doi: 10.1186/s12905-023-02237-y.
5
Endometrial stromal tumors of the uterus: Epidemiology, pathological and biological features, treatment options and clinical outcomes.子宫子宫内膜间质肿瘤:流行病学、病理及生物学特征、治疗选择与临床结局
Gynecol Oncol. 2023 Apr;171:95-105. doi: 10.1016/j.ygyno.2023.02.009. Epub 2023 Feb 24.
6
Pulmonary benign metastasizing leiomyoma: a report of two cases.肺良性转移性平滑肌瘤:2例报告
Future Sci OA. 2022 Sep 23;8(8):FSO814. doi: 10.2144/fsoa-2022-0021. eCollection 2022 Sep.
7
Integrative Analysis Identifies TCIRG1 as a Potential Prognostic and Immunotherapy-Relevant Biomarker Associated with Malignant Cell Migration in Clear Cell Renal Cell Carcinoma.综合分析确定TCIRG1是一种与透明细胞肾细胞癌中恶性细胞迁移相关的潜在预后和免疫治疗相关生物标志物。
Cancers (Basel). 2022 Sep 21;14(19):4583. doi: 10.3390/cancers14194583.
8
Benign Metastasizing Leiomyomatosis to the Skin and Lungs, Intravenous Leiomyomatosis, and Leiomyomatosis Peritonealis Disseminata: A Series of Five Cases.良性转移性平滑肌瘤病至皮肤和肺部、静脉内平滑肌瘤病和播散性腹膜平滑肌瘤病:五例系列病例。
Oncologist. 2022 Feb 3;27(1):e89-e98. doi: 10.1093/oncolo/oyab019.
9
CircRNA hsa_circ_0014130 function as a miR-132-3p sponge for playing oncogenic roles in bladder cancer via upregulating KCNJ12 expression.环状 RNA hsa_circ_0014130 通过上调 KCNJ12 表达充当 miR-132-3p 的海绵,从而在膀胱癌中发挥致癌作用。
Cell Biol Toxicol. 2022 Dec;38(6):1079-1096. doi: 10.1007/s10565-021-09668-z. Epub 2021 Nov 9.
10
T cell immune regulator 1 is a prognostic marker associated with immune infiltration in glioblastoma multiforme.T细胞免疫调节因子1是与多形性胶质母细胞瘤免疫浸润相关的预后标志物。
Oncol Lett. 2021 Apr;21(4):252. doi: 10.3892/ol.2021.12514. Epub 2021 Feb 3.